Veracyte Announces Multiple Decipher Urologic Testing Abstra

Veracyte, Inc. today announced that six abstracts highlighting new data focused on the company’s Decipher urologic cancer testing offerings will be presented at the 2023 ASCO Genitourinary ... | February 1, 2023

Related Keywords

California , United States , United Kingdom , South San Francisco , Michigan , San Francisco , British , Adam Benjamin Weiner , Himanshu Nagar , Shilpa Gupta , Moritz Reike , Gerhardt Attard , Elai Davicioni , Ariele Marciscano , Cleveland Clinic Taussig Cancer Center , Twitter , Weill Cornell Medical College , Nasdaq , University Of Michigan , University Of British Columbia , Moscone Center , Veracyte Inc , University College London Cancer Institute , Cancers Symposium , Decipher Genomics Resource , Intelligent Discovery , Decipher Prostate Genomic Classifier , Michigan Impacting Observation , Decipher Prostate , Patients Starting Androgen Deprivation Therapy , Recent Victories , Moscone West , Benjamin Weiner , Weill Cornell Medicine , British Columbia , Bladder Cancer Signal Seeking Trial , Counter Analysis System , Annual Report , Quarterly Report , Nanostring Technologies , Veracyte , Nc Stock Exchange , News , Information , Press Release , Oday , Nnounced , Hat , Six , Abstracts , Ighlighting , Few , Data , Ocused , N , The , Decipher , Irologic , Dancer , Testing , Offerings , Hill , He , Resented , It , 023 , Disco , Enitourinary Vcyt Us92337f1075 ,